Filing Flows › Camp4 Therapeutics (CAMP) › R&D spending
Camp4 Therapeutics (CAMP) R&D spending by quarter
Camp4 Therapeutics' R&D spending was $11.4M in Q3 2026 (third quarter 2026), +6% from Q2 2026. Over the last 6 quarters it ranged from $9.4M (Q3 2025) to $11.4M (Q3 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $11.4M | +6% | +22% |
| Q2 2026 | $10.8M | +6% | +5% |
| Q1 2026 | $10.2M | +9% | +0.1% |
| Q3 2025 | $9.4M | -10% | — |
| Q2 2025 | $10.3M | +2% | — |
| Q1 2025 | $10.1M | — | — |
Q3 2026 at a glance
Camp4 Therapeutics, Q3 2026: revenue $1.9M (+139% year over year), operating margin -738.8%, net loss $29.0M, operating cash flow −$8.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Camp4 Therapeutics' R&D spending?
Camp4 Therapeutics' R&D spending was $11.4M in Q3 2026 (third quarter 2026), +6% from Q2 2026.
How has Camp4 Therapeutics' R&D spending changed?
Over the last 6 quarters it ranged from $9.4M (Q3 2025) to $11.4M (Q3 2026).